BR112012015677A2 - Compostos farmacêuticos. - Google Patents
Compostos farmacêuticos.Info
- Publication number
- BR112012015677A2 BR112012015677A2 BRBR112012015677-2A BR112012015677A BR112012015677A2 BR 112012015677 A2 BR112012015677 A2 BR 112012015677A2 BR 112012015677 A BR112012015677 A BR 112012015677A BR 112012015677 A2 BR112012015677 A2 BR 112012015677A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical compounds
- compounds
- pharmaceutical
- methods
- well
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 229940043355 kinase inhibitor Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0922589.7A GB0922589D0 (en) | 2009-12-23 | 2009-12-23 | Pharmaceutical compounds |
| PCT/GB2010/002329 WO2011077098A1 (en) | 2009-12-23 | 2010-12-23 | Inhibitors of akt activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012015677A2 true BR112012015677A2 (pt) | 2015-06-30 |
Family
ID=41716932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRBR112012015677-2A BR112012015677A2 (pt) | 2009-12-23 | 2010-12-23 | Compostos farmacêuticos. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9221838B2 (https=) |
| EP (1) | EP2516435B8 (https=) |
| JP (1) | JP5923043B2 (https=) |
| KR (1) | KR20140015157A (https=) |
| CN (1) | CN102791708B (https=) |
| AU (1) | AU2010334591C1 (https=) |
| BR (1) | BR112012015677A2 (https=) |
| CA (1) | CA2783340C (https=) |
| CY (1) | CY1115686T1 (https=) |
| DK (1) | DK2516435T3 (https=) |
| ES (1) | ES2503794T3 (https=) |
| GB (1) | GB0922589D0 (https=) |
| IL (1) | IL220153A (https=) |
| MX (1) | MX2012007274A (https=) |
| NZ (1) | NZ600453A (https=) |
| PL (1) | PL2516435T3 (https=) |
| PT (1) | PT2516435E (https=) |
| RU (1) | RU2579513C2 (https=) |
| SG (1) | SG181517A1 (https=) |
| SI (1) | SI2516435T1 (https=) |
| WO (1) | WO2011077098A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201205164D0 (en) * | 2012-03-23 | 2012-05-09 | Almac Discovery Ltd | Pharmaceutical compounds |
| JP6787899B2 (ja) * | 2014-12-23 | 2020-11-18 | ベルゲンビオ アーエスアー | 医薬的活性化合物 |
| US10323044B2 (en) * | 2015-02-27 | 2019-06-18 | Taiho Pharmaceutical Co., Ltd. | Crystal of imidazo-oxazine, pharmaceutical composition containing said crystal, and method for producing said crystal |
| GB201603779D0 (en) | 2016-03-04 | 2016-04-20 | Mission Therapeutics Ltd | Novel compounds |
| MA45865A (fr) * | 2016-08-07 | 2021-04-14 | Wistar Inst | Procédés de détection et de traitement d'une tumeur exprimant pt346 pdk1 |
| UA125730C2 (uk) * | 2017-06-22 | 2022-05-25 | Курадев Фарма Лімітед | Низькомолекулярні модулятори sting людини |
| MX2020002611A (es) | 2017-09-07 | 2020-07-13 | Univ Res Inst Inc Augusta | Activador especifico de akt3 y usos del mismo. |
| GB2600384A (en) * | 2020-09-30 | 2022-05-04 | Vaderis Therapeutics Ag | Allosteric AKT inhibitors for use in the treatment of hereditary hemorrhagic telangiectasia |
| WO2025250545A1 (en) * | 2024-05-28 | 2025-12-04 | Alterome Therapeutics, Inc. | Akt1 modulators |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL181893B1 (pl) * | 1994-11-14 | 2001-10-31 | Warner Lambert Co | Zwiazki bedace pochodnymi pirymidyny i naftyrydyny oraz preparat farmaceutyczny zawierajacy je PL PL PL |
| TWI301760B (en) * | 2004-02-27 | 2008-10-11 | Merz Pharma Gmbh & Co Kgaa | Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors |
| US7910561B2 (en) * | 2004-12-15 | 2011-03-22 | Merck Sharp & Dohme Corp. | Inhibitors of Akt activity |
| EP1898903B8 (en) * | 2005-06-10 | 2013-05-15 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
| WO2008011032A1 (en) * | 2006-07-17 | 2008-01-24 | Amgen Inc. | Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors |
| JP2010512312A (ja) | 2006-12-06 | 2010-04-22 | メルク エンド カムパニー インコーポレーテッド | Ａｋｔ活性の阻害剤 |
| AR064010A1 (es) | 2006-12-06 | 2009-03-04 | Merck & Co Inc | Inhibidores de la actividad de la akt |
| US7999107B2 (en) * | 2007-01-31 | 2011-08-16 | Merck Sharp & Dohme Corp. | Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators |
| JP2011522048A (ja) * | 2008-06-03 | 2011-07-28 | メルク・シャープ・エンド・ドーム・コーポレイション | Ａｋｔ活性の阻害剤 |
| US8536193B2 (en) | 2008-06-03 | 2013-09-17 | Merck Sharp & Dohme Corp. | Inhibitors of AKT activity |
-
2009
- 2009-12-23 GB GBGB0922589.7A patent/GB0922589D0/en not_active Ceased
-
2010
- 2010-12-23 BR BRBR112012015677-2A patent/BR112012015677A2/pt not_active Application Discontinuation
- 2010-12-23 SG SG2012041232A patent/SG181517A1/en unknown
- 2010-12-23 US US13/517,219 patent/US9221838B2/en active Active
- 2010-12-23 CA CA2783340A patent/CA2783340C/en not_active Expired - Fee Related
- 2010-12-23 CN CN201080059321.9A patent/CN102791708B/zh active Active
- 2010-12-23 AU AU2010334591A patent/AU2010334591C1/en not_active Ceased
- 2010-12-23 JP JP2012545434A patent/JP5923043B2/ja active Active
- 2010-12-23 MX MX2012007274A patent/MX2012007274A/es active IP Right Grant
- 2010-12-23 PL PL10800980T patent/PL2516435T3/pl unknown
- 2010-12-23 DK DK10800980.4T patent/DK2516435T3/da active
- 2010-12-23 PT PT108009804T patent/PT2516435E/pt unknown
- 2010-12-23 EP EP10800980.4A patent/EP2516435B8/en active Active
- 2010-12-23 SI SI201030774T patent/SI2516435T1/sl unknown
- 2010-12-23 WO PCT/GB2010/002329 patent/WO2011077098A1/en not_active Ceased
- 2010-12-23 KR KR1020127019033A patent/KR20140015157A/ko not_active Ceased
- 2010-12-23 NZ NZ600453A patent/NZ600453A/xx not_active IP Right Cessation
- 2010-12-23 ES ES10800980.4T patent/ES2503794T3/es active Active
- 2010-12-23 RU RU2012131115/04A patent/RU2579513C2/ru not_active IP Right Cessation
-
2012
- 2012-06-04 IL IL220153A patent/IL220153A/en not_active IP Right Cessation
-
2014
- 2014-10-31 CY CY20141100899T patent/CY1115686T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP5923043B2 (ja) | 2016-05-24 |
| SI2516435T1 (sl) | 2014-12-31 |
| RU2579513C2 (ru) | 2016-04-10 |
| ES2503794T3 (es) | 2014-10-07 |
| PL2516435T3 (pl) | 2015-01-30 |
| KR20140015157A (ko) | 2014-02-06 |
| MX2012007274A (es) | 2012-10-03 |
| AU2010334591B2 (en) | 2014-04-10 |
| GB0922589D0 (en) | 2010-02-10 |
| EP2516435B8 (en) | 2014-10-15 |
| AU2010334591C1 (en) | 2014-07-31 |
| IL220153A0 (en) | 2012-07-31 |
| DK2516435T3 (da) | 2014-10-13 |
| EP2516435A1 (en) | 2012-10-31 |
| US9221838B2 (en) | 2015-12-29 |
| RU2012131115A (ru) | 2014-01-27 |
| HK1171013A1 (en) | 2013-03-15 |
| JP2013515710A (ja) | 2013-05-09 |
| US20130116243A1 (en) | 2013-05-09 |
| EP2516435B1 (en) | 2014-08-06 |
| CN102791708A (zh) | 2012-11-21 |
| IL220153A (en) | 2015-05-31 |
| NZ600453A (en) | 2013-10-25 |
| CA2783340C (en) | 2015-11-24 |
| CA2783340A1 (en) | 2011-06-30 |
| WO2011077098A1 (en) | 2011-06-30 |
| CY1115686T1 (el) | 2017-01-25 |
| WO2011077098A9 (en) | 2012-04-19 |
| CN102791708B (zh) | 2016-03-02 |
| AU2010334591A1 (en) | 2012-06-21 |
| PT2516435E (pt) | 2014-11-13 |
| SG181517A1 (en) | 2012-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012015677A2 (pt) | Compostos farmacêuticos. | |
| PY1212975A (es) | Compuestos de azabiclo o quinuclidin-carbamato como inhibidores de glucosilceramida sintasa | |
| CR20140161A (es) | Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas | |
| WO2011033265A8 (en) | Pharmaceutical compounds | |
| CO6480975A2 (es) | Mimetico de smac | |
| CU24263B1 (es) | Derivados de imidazopiridazinas inhibidores de quinasa akt, útiles para el tratamiento del cáncer | |
| TN2012000578A1 (en) | Tetrahydro-pyrido-pyrimidine derivatives | |
| CU24097B1 (es) | Compuestos piridiloxi-indoles sustituidos como inhibidores del vegf-r2 útiles para el tratamiento de enfermedades proliferativas | |
| EA201400833A1 (ru) | Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
| BR112014018959A8 (pt) | Compostos, composições farmacêuticas, utilizações de um composto e métodos para o tratamento do câncer | |
| TR201816379T4 (tr) | DNA-PK inhibitörleri. | |
| DOP2015000039A (es) | Inhibidores de glucosilceramida sintasa | |
| CR20140361A (es) | Inhibidores de pde9 con estructura básica de imidazotriazinona | |
| PH12013501618A1 (en) | New azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors | |
| PH12013502059A1 (en) | Pyrrolotriazinone derivatives as p13k inhibitors | |
| BR112012020693A2 (pt) | derivados de ciclobutano e metilciclobutano como inibidores de janus quinase | |
| CR11757A (es) | Compuestos de triazina como inhibidores mtor y quinasa pi3 | |
| BR112012011528A2 (pt) | métodos para inibir uma proteína quinase e para tratar uma doença associada com atividade de quinase, e, composto | |
| JO3419B1 (ar) | مركبات بيريدوبيرازين مضادة للسرطان من خلال تثبيط إنزيمات كيناز fgfr | |
| BR112012010186B8 (pt) | derivados de heteroarila contendo n como inibidores de quinase jak3 e composição farmacêutica compreendendo os mesmos | |
| MX374452B (es) | Inhibidores de glucosilceramida sintasa para el tratamiento de enfermedades. | |
| CO6771439A2 (es) | Inhibidores de benzodioxano de la producción de leucotrieno | |
| MX347241B (es) | Derivados de aminopirimidina para usarse como moduladores de la actividad de cinasa. | |
| GEP201706623B (en) | Pyrrolotriazinone derivatives as pi3k inhibitors | |
| PH12016500092A1 (en) | New azabenzimidazole derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B65X | Notification of requirement for priority examination of patent application | ||
| B65Y | Grant of priority examination of the patent application (request complies with dec. 132/06 of 20061117) | ||
| B15G | Petition not considered as such [chapter 15.7 patent gazette] |
Free format text: DESCONHECIDA A PETICAO NO RJ860140134878 DE 11/08/2014 COM BASE NO DISPOSTO NO ART. 219, II DA LEI DA PROPRIEDADE INDUSTRIAL, UMA VEZ QUE JA FOI CONCEDIDO O EXAME PRIORITARIO DO PEDIDO DE PATENTE. |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |